Use of a targeted oncolytic poxvirus, JX-594, in patients with refractory primary or metastatic liver cancer: a phase I trial.
暂无分享,去创建一个
D. Sze | D. Kirn | S. Han | J. Bell | A. Moon | S. Oh | B. Rhee | T. Hwang | M. Daneshmand | Kelly Speth | B. Park | Ta-Chiang Liu | Jae-Seok Kim | H. Kwon | J. Yoon | S. Hong | C. Park | Young-Joo Ahn | H. Pinedo | Kelly A Speth